Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,336 | -12,824 | -6,364 | -31,154 | -22,709 |
| Depreciation Amortization | 71 | 47 | 23 | 77 | 17 |
| Accounts payable and accrued liabilities | -898 | -1,341 | -509 | 917 | 638 |
| Other Working Capital | -6,347 | -4,621 | -3,470 | 5,506 | 4,013 |
| Other Operating Activity | 9,268 | 4,735 | 1,676 | 2,337 | 1,669 |
| Operating Cash Flow | $-19,242 | $-14,004 | $-8,644 | $-22,317 | $-16,372 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -405,050 | -183,035 | -102,122 | -21,881 | -27,966 |
| PPE Investments | -14 | -1 | -1 | -125 | -125 |
| Investing Cash Flow | $-405,064 | $-183,036 | $-102,123 | $-22,006 | $-28,091 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 313,725 | 313,274 | 265 | 173,805 | 38,278 |
| Financing Cash Flow | $313,725 | $313,274 | $265 | $173,805 | $38,278 |
| Beginning Cash Position | 148,627 | 148,627 | 148,627 | 19,145 | 19,145 |
| End Cash Position | 38,046 | 264,861 | 38,125 | 148,627 | 12,960 |
| Net Cash Flow | $-110,581 | $116,234 | $-110,502 | $129,482 | $-6,185 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,242 | -14,004 | -8,644 | -22,317 | -16,372 |
| Capital Expenditure | -14 | -1 | -1 | -125 | -125 |
| Free Cash Flow | -19,256 | -14,005 | -8,645 | -22,442 | -16,497 |